EXPERIENCE ACCESS EXCELLENCE WITH KYNMOBI

Easy,* affordable access with a high rate of prescription approval1-3

KYNMOBI is covered for:

MEDICARE PART D PATIENTS

with 75% paying between
$0 and $75—and most
paying $25 or less1,3

COMMERCIAL PATIENTS

with 19% paying $0,
and eligible commercial
patients may pay $151,3

*36.5% of commercial and 5.2% of Medicare Part D patients have unrestricted access. Data current as of July 20, 2021. Prior authorization approval rates for commercial and Medicare Part D patients are 73% and 95%, respectively. The overall approval rate for KYNMOBI is 85%. Data current as of June 2021.1,2

Up to 62% of commercial and Medicare Part D patients pay $25 or less for their KYNMOBI prescription. Data current as of June 1, 2021.

KYNMOBI is covered on 87% of commercial plans and 88% of Medicare Part D plans. Inbrija® (levodopa inhalation powder) is covered at 86% for commercial plans, with most prescriptions managed through prior authorizations. Apokyn® (apomorphine hydrochloride injection) is covered at 69% for commercial patients. KYNMOBI continues to have higher coverage compared to Inbrija, which is covered at 22% for Medicare Part D patients. Data current as of July 20, 2021. KYNMOBI demonstrates superior coverage across all payers with approvals at 76% compared to 25% for Apokyn and 70% for Inbrija. Data current as of June 30, 2021.1,3

References: 1. Fingertip Formulary. Data on file. Sunovion Pharamaceuticals Inc. 2. CoverMyMeds Brand Report, June 2021. Data on file. Sunovion Pharamaceuticals Inc. 3. IQVIA FIA Data. Data on file. Sunovion Pharamaceuticals Inc.

The KYNMOBI® (apomorphine HCl) Savings Program offers 2 ways to help patients save on medication costs*

With the KYNMOBI Copay Savings Card, patients can pay as little as $15 a month per 30‐count carton if they meet the eligibility requirements.

Not actual card.

Individual copay amounts may vary. A maximum benefit limit also applies. Eligibility requirements and restrictions apply.
See KYNMOBI Savings Program Terms and Conditions.

circle 1

Eligible commercially insured patients may pay as little as $15 per 30-count carton with the KYNMOBI Copay Savings Card

circle 2

Eligible uninsured, cash-paying patients may pay as little as $195 per 30-count carton with the KYNMOBI Copay Savings Card

There are 2 ways to obtain a KYNMOBI Copay Savings Card for your patient:

  1. Via the Patient Starter Kit, in which one is provided
  2. By calling your Therapeutic Specialist to have one delivered to your office
No annual cap. Up to 5 cartons per month, if patients meet eligibility requirements
Top

Thank you for registering with KYNMOBI!

We look forward to telling you more about KYNMOBI, a new medication to treat OFF episodes associated with Parkinson's disease, as it becomes available.

You have been successfully unsubscribed.

Please allow 7-10 days to process your request.